Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:Xestoaminol C)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteUnits(range)
ST001795 AN002915 Changes in mesenteric lymph lipid profile of mice upon high-fat diet with and without Celecoxib (part I) Mesenteric lymph Mouse Obesity Monash Institute of Pharmaceutical Sciences height
ST001788 AN002899 β-Adrenergic regulation of metabolism in macrophages (part-IV) Macrophages Human Monash University Intensity
ST003044 AN004994 A High-Fat Eucaloric Diet Induces Reprometabolic Syndrome of Obesity in Normal Weight Women - lipidomics Blood Human Obesity University of Colorado Denver peak area
ST000311 AN000495 TC and B6 untreated plasma in lupus-prone mice Blood Mouse Lupus University of Florida Peak area
ST000612 AN000937 Sphingolipid Analysis of Human Aqueous Humor in Glaucomatous and Control eyes Eye tissue Human Eye disease University of Miami Peak area
ST000613 AN000938 Human TM Sphingolipid Analysis (part II) Eye tissue Human Eye disease University of Miami Peak area
ST000620 AN000952 Sphingolipid Analysis of hyper and normotensive DBA2J mice aqueous humor and trabecular meshwork Mouse Eye disease University of Miami Peak area
ST002792 AN004542 Chemoproteomics validates selective targeting of Plasmodium M1 alanyl aminopeptidase as a cross-species strategy to treat malaria Blood Plasmodium falciparum Malaria Monash University peak height
ST003144 AN005159 On-target, dual aminopeptidase inhibition provides cross-species antimalarial activity Blood Plasmodium falciparum Malaria Monash University peak height
ST000311 AN000497 TC and B6 untreated plasma in lupus-prone mice Blood Mouse Lupus University of Florida Peak height
ST001274 AN002115 Metabolomics-based profiling of the mode of action of Pathogen Box compounds in Trypanosoma brucei (part-I) Cultured cells Trypanosoma brucei Sleeping sickness Monash University Peak height
ST001276 AN002117 Development and Characterisation of a Novel Class of Aroyl Guanidine Containing Anti-Trypanosomal Compounds Cultured cells Trypanosoma brucei Sleeping sickness Monash University Peak height
ST001202 AN002000 Peroxide antimalarial treatment timecourse on ring-stage P. falciparum parasites Cultured cells Human Malaria Monash University Peak intensity
ST001202 AN002000 Peroxide antimalarial treatment timecourse on ring-stage P. falciparum parasites Cultured cells Plasmodium falciparum Malaria Monash University Peak intensity
ST001204 AN002004 Peroxide antimalarial extended treatment timecourse on trophozoite-stage P. falciparum parasites Cultured cells Human Malaria Monash University Peak intensity
ST001204 AN002004 Peroxide antimalarial extended treatment timecourse on trophozoite-stage P. falciparum parasites Cultured cells Plasmodium falciparum Malaria Monash University Peak intensity
ST001547 AN002576 β-Adrenergic regulation of metabolism in macrophages Macrophages Human Monash University Peak intensity
ST001548 AN002578 β-Adrenergic regulation of metabolism in macrophages (part-II) Macrophages Human Monash University Peak intensity
ST001549 AN002580 β-Adrenergic regulation of metabolism in macrophages (part-III) Macrophages Human Monash University Peak intensity
ST002094 AN003420 Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1) Feces Human Irritable bowel syndrome Mayo Clinic raw intensity
ST002094 AN003421 Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1) Feces Human Irritable bowel syndrome Mayo Clinic raw intensity
  logo